Evaluation of facial complications of hyaluronic acid fillers

Evaluation of facial complications of hyaluronic acid fillers

Objectives: This study aims to evaluate facial complications of dermal fillers and to increase the public awareness about seriousadverse outcomes of these applications.Patients and Methods: Between January 2015 and June 2019, a total of 12 patients (2 males, 10 females; mean age 41 years; range,28 to 64 years) who experienced hyaluronic acid (HA) filler-related complications were retrospectively analyzed. Complications wererecorded using the hospital records.Results: The mean follow-up was 7 (range, 6 to 9) months. In one patient, livedo reticularis over the nose caused by the filler tothe nasolabial fold was seen. In another patient, livedo reticularis over the nose caused by the HA filler for tip augmentation wasobserved. Both patients were treated with heating and oral acetylsalicylic acid. In another two patients, cellulitic infections wereobserved. Oral antibiotics and topical antibiotic cream were applied. In two patients, infraorbital edema was seen caused by HAfiller application to the nasojugal folds. Hyaluronidase was applied for treatment. In two patients, a granuloma was seen at the rightinfraorbital region and at the left nasolabial region, respectively. Both of them were treated with hyaluronidase. In one patient, agranuloma and infectious abscess of the upper lip caused by the HA filler application for lip augmentation was observed. For thetreatment of the abscess, surgical drainage was used and hyaluronidase was applied for the treatment of the granuloma. In threepatients, bruising was observed which was treated with the Arnica cream.Conclusion: Our study results show that fillers are not completely innocent products. We recommend that these materials shouldbe used in experienced hands in accordance with the relevant regulations.

___

  • 1. Vedamurthy M. Beware What You Inject: Complications of Injectables-Dermal Fillers. J Cutan Aesthet Surg 2018;11:60-6.
  • 2. Rzany B, DeLorenzi C. Understanding, Avoiding, and Managing Severe Filler Complications. Plast Reconstr Surg 2015;136:196-203.
  • 3. DeLorenzi C. Complications of injectable fillers, part 2: vascular complications. Aesthet Surg J 2014;34:584-600.
  • 4. Buhren BA, Schrumpf H, Hoff NP, Bölke E, Hilton S, Gerber PA. Hyaluronidase: from clinical applications to molecular and cellular mechanisms. Eur J Med Res 2016;21:5.
  • 5. Carruthers JD, Fagien S, Rohrich RJ, Weinkle S, Carruthers A. Blindness caused by cosmetic filler injection: a review of cause and therapy. Plast Reconstr Surg 2014;134:1197-201.
  • 6. Hexsel D, Soirefmann M, Porto MD, Siega C, SchillingSouza J, Brum C. Double-blind, randomized, controlled clinical trial to compare safety and efficacy of a metallic cannula with that of a standard needle for soft tissue augmentation of the nasolabial folds. Dermatol Surg 2012;38:207-14.
  • 7. Signorini M, Liew S, Sundaram H, De Boulle KL, Goodman GJ, Monheit G, et al. Global Aesthetics Consensus: Avoidance and Management of Complications from Hyaluronic Acid FillersEvidence- and Opinion-Based Review and Consensus Recommendations. Plast Reconstr Surg 2016;137:961-71.